Spice-Derived Bioactive Ingredients: Potential Agents or Food Adjuvant in the Management of Diabetes Mellitus

about

Spice-Derived Bioactive Ingredients: Potential Agents or Food Adjuvant in the Management of Diabetes Mellitus

Item

http://www.wikidata.org/entity/Q57167981

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Spice-Derived Bioactive Ingred ...... anagement of Diabetes Mellitus

@en

Spice-Derived Bioactive Ingred ...... anagement of Diabetes Mellitus

@nl

type

Item

label

Spice-Derived Bioactive Ingred ...... anagement of Diabetes Mellitus

@en

Spice-Derived Bioactive Ingred ...... anagement of Diabetes Mellitus

@nl

prefLabel

Spice-Derived Bioactive Ingred ...... anagement of Diabetes Mellitus

@en

Spice-Derived Bioactive Ingred ...... anagement of Diabetes Mellitus

@nl

P1476

Spice-Derived Bioactive Ingred ...... anagement of Diabetes Mellitus

@en

P2093

Aminu Mohammed

http://www.w3.org/2001/XMLSchema#string

Md Shahidul Islam

http://www.w3.org/2001/XMLSchema#string

P2860

Curcumin and diabetes: a systematic review

Changes in levels of nerve growth factor in nasal secretions after capsaicin inhalation in patients with airway symptoms from scents and chemicals.

Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging

4-Hydroxyisoleucine from Fenugreek (Trigonella foenum-graecum): Effects on Insulin Resistance Associated with Obesity

Bioavailability of curcumin: problems and promises

Gingerols and shogaols: Important nutraceutical principles from ginger

Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects

Anti-obesity and anti-hyperglycemic effects of cinnamaldehyde via altered ghrelin secretion and functional impact on food intake and gastric emptying

Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model

Diosgenin from Dioscorea bulbifera: novel hit for treatment of type II diabetes mellitus with inhibitory activity against α-amylase and α-glucosidase

P304

893

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.00893

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30186162

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6113848

http://www.w3.org/2001/XMLSchema#string